Global Solid Preparation Drug Market Research Report 2023

Solid Preparation Drug Market

Solid dosage form means any of the many pharmacy dosage forms like tablets, capsules, caplets, pills, powders, troches, lozenges, cachets, pellets or confections which are solid and which are not in liquid or gaseous form.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Solid Preparation Drug market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Solid Preparation Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Solid Preparation Drug Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Solid Preparation Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Tablet

1.2.3 Capsules

1.2.4 Other

1.3 Market by Application

1.3.1 Global Solid Preparation Drug Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Solid Preparation Drug Market Perspective (2018-2029)

2.2 Solid Preparation Drug Growth Trends by Region

2.2.1 Global Solid Preparation Drug Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Solid Preparation Drug Historic Market Size by Region (2018-2023)

2.2.3 Solid Preparation Drug Forecasted Market Size by Region (2024-2029)

2.3 Solid Preparation Drug Market Dynamics

2.3.1 Solid Preparation Drug Industry Trends

2.3.2 Solid Preparation Drug Market Drivers

2.3.3 Solid Preparation Drug Market Challenges

2.3.4 Solid Preparation Drug Market Restraints

3.1 Global Top Solid Preparation Drug Players by Revenue

3.1.1 Global Top Solid Preparation Drug Players by Revenue (2018-2023)

3.1.2 Global Solid Preparation Drug Revenue Market Share by Players (2018-2023)

3.2 Global Solid Preparation Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Solid Preparation Drug Revenue

3.4 Global Solid Preparation Drug Market Concentration Ratio

3.4.1 Global Solid Preparation Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Solid Preparation Drug Revenue in 2022

3.5 Solid Preparation Drug Key Players Head office and Area Served

3.6 Key Players Solid Preparation Drug Product Solution and Service

3.7 Date of Enter into Solid Preparation Drug Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Solid Preparation Drug Historic Market Size by Type (2018-2023)

4.2 Global Solid Preparation Drug Forecasted Market Size by Type (2024-2029)

5.1 Global Solid Preparation Drug Historic Market Size by Application (2018-2023)

5.2 Global Solid Preparation Drug Forecasted Market Size by Application (2024-2029)

6.1 North America Solid Preparation Drug Market Size (2018-2029)

6.2 North America Solid Preparation Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Solid Preparation Drug Market Size by Country (2018-2023)

6.4 North America Solid Preparation Drug Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Solid Preparation Drug Market Size (2018-2029)

7.2 Europe Solid Preparation Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Solid Preparation Drug Market Size by Country (2018-2023)

7.4 Europe Solid Preparation Drug Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Solid Preparation Drug Market Size (2018-2029)

8.2 Asia-Pacific Solid Preparation Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Solid Preparation Drug Market Size by Region (2018-2023)

8.4 Asia-Pacific Solid Preparation Drug Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Solid Preparation Drug Market Size (2018-2029)

9.2 Latin America Solid Preparation Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Solid Preparation Drug Market Size by Country (2018-2023)

9.4 Latin America Solid Preparation Drug Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Solid Preparation Drug Market Size (2018-2029)

10.2 Middle East & Africa Solid Preparation Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Solid Preparation Drug Market Size by Country (2018-2023)

10.4 Middle East & Africa Solid Preparation Drug Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Johnson & Johnson

11.1.1 Johnson & Johnson Company Detail

11.1.2 Johnson & Johnson Business Overview

11.1.3 Johnson & Johnson Solid Preparation Drug Introduction

11.1.4 Johnson & Johnson Revenue in Solid Preparation Drug Business (2018-2023)

11.1.5 Johnson & Johnson Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Solid Preparation Drug Introduction

11.2.4 Novartis Revenue in Solid Preparation Drug Business (2018-2023)

11.2.5 Novartis Recent Development

11.3 Roche

11.3.1 Roche Company Detail

11.3.2 Roche Business Overview

11.3.3 Roche Solid Preparation Drug Introduction

11.3.4 Roche Revenue in Solid Preparation Drug Business (2018-2023)

11.3.5 Roche Recent Development

11.4 AbbVie

11.4.1 AbbVie Company Detail

11.4.2 AbbVie Business Overview

11.4.3 AbbVie Solid Preparation Drug Introduction

11.4.4 AbbVie Revenue in Solid Preparation Drug Business (2018-2023)

11.4.5 AbbVie Recent Development

11.5 Merck & Co.

11.5.1 Merck & Co. Company Detail

11.5.2 Merck & Co. Business Overview

11.5.3 Merck & Co. Solid Preparation Drug Introduction

11.5.4 Merck & Co. Revenue in Solid Preparation Drug Business (2018-2023)

11.5.5 Merck & Co. Recent Development

11.6 Bristol Myers Squibb

11.6.1 Bristol Myers Squibb Company Detail

11.6.2 Bristol Myers Squibb Business Overview

11.6.3 Bristol Myers Squibb Solid Preparation Drug Introduction

11.6.4 Bristol Myers Squibb Revenue in Solid Preparation Drug Business (2018-2023)

11.6.5 Bristol Myers Squibb Recent Development

11.7 GlaxoSmithKline

11.7.1 GlaxoSmithKline Company Detail

11.7.2 GlaxoSmithKline Business Overview

11.7.3 GlaxoSmithKline Solid Preparation Drug Introduction

11.7.4 GlaxoSmithKline Revenue in Solid Preparation Drug Business (2018-2023)

11.7.5 GlaxoSmithKline Recent Development

11.8 Pfizer

11.8.1 Pfizer Company Detail

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Solid Preparation Drug Introduction

11.8.4 Pfizer Revenue in Solid Preparation Drug Business (2018-2023)

11.8.5 Pfizer Recent Development

11.9 Sanofi

11.9.1 Sanofi Company Detail

11.9.2 Sanofi Business Overview

11.9.3 Sanofi Solid Preparation Drug Introduction

11.9.4 Sanofi Revenue in Solid Preparation Drug Business (2018-2023)

11.9.5 Sanofi Recent Development

11.10 Takeda

11.10.1 Takeda Company Detail

11.10.2 Takeda Business Overview

11.10.3 Takeda Solid Preparation Drug Introduction

11.10.4 Takeda Revenue in Solid Preparation Drug Business (2018-2023)

11.10.5 Takeda Recent Development

11.11 AstraZeneca

11.11.1 AstraZeneca Company Detail

11.11.2 AstraZeneca Business Overview

11.11.3 AstraZeneca Solid Preparation Drug Introduction

11.11.4 AstraZeneca Revenue in Solid Preparation Drug Business (2018-2023)

11.11.5 AstraZeneca Recent Development

11.12 Bayer

11.12.1 Bayer Company Detail

11.12.2 Bayer Business Overview

11.12.3 Bayer Solid Preparation Drug Introduction

11.12.4 Bayer Revenue in Solid Preparation Drug Business (2018-2023)

11.12.5 Bayer Recent Development

11.13 Eli Lilly & Co.

11.13.1 Eli Lilly & Co. Company Detail

11.13.2 Eli Lilly & Co. Business Overview

11.13.3 Eli Lilly & Co. Solid Preparation Drug Introduction

11.13.4 Eli Lilly & Co. Revenue in Solid Preparation Drug Business (2018-2023)

11.13.5 Eli Lilly & Co. Recent Development

11.14 Gilead Sciences

11.14.1 Gilead Sciences Company Detail

11.14.2 Gilead Sciences Business Overview

11.14.3 Gilead Sciences Solid Preparation Drug Introduction

11.14.4 Gilead Sciences Revenue in Solid Preparation Drug Business (2018-2023)

11.14.5 Gilead Sciences Recent Development

11.15 Amgen

11.15.1 Amgen Company Detail

11.15.2 Amgen Business Overview

11.15.3 Amgen Solid Preparation Drug Introduction

11.15.4 Amgen Revenue in Solid Preparation Drug Business (2018-2023)

11.15.5 Amgen Recent Development

11.16 Teva

11.16.1 Teva Company Detail

11.16.2 Teva Business Overview

11.16.3 Teva Solid Preparation Drug Introduction

11.16.4 Teva Revenue in Solid Preparation Drug Business (2018-2023)

11.16.5 Teva Recent Development

11.17 Boehringer Ingelheim

11.17.1 Boehringer Ingelheim Company Detail

11.17.2 Boehringer Ingelheim Business Overview

11.17.3 Boehringer Ingelheim Solid Preparation Drug Introduction

11.17.4 Boehringer Ingelheim Revenue in Solid Preparation Drug Business (2018-2023)

11.17.5 Boehringer Ingelheim Recent Development

11.18 Biogen

11.18.1 Biogen Company Detail

11.18.2 Biogen Business Overview

11.18.3 Biogen Solid Preparation Drug Introduction

11.18.4 Biogen Revenue in Solid Preparation Drug Business (2018-2023)

11.18.5 Biogen Recent Development

11.19 Astellas

11.19.1 Astellas Company Detail

11.19.2 Astellas Business Overview

11.19.3 Astellas Solid Preparation Drug Introduction

11.19.4 Astellas Revenue in Solid Preparation Drug Business (2018-2023)

11.19.5 Astellas Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Solid Preparation Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Tablet

    Table 3. Key Players of Capsules

    Table 4. Key Players of Other

    Table 5. Global Solid Preparation Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Solid Preparation Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Solid Preparation Drug Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Solid Preparation Drug Market Share by Region (2018-2023)

    Table 9. Global Solid Preparation Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Solid Preparation Drug Market Share by Region (2024-2029)

    Table 11. Solid Preparation Drug Market Trends

    Table 12. Solid Preparation Drug Market Drivers

    Table 13. Solid Preparation Drug Market Challenges

    Table 14. Solid Preparation Drug Market Restraints

    Table 15. Global Solid Preparation Drug Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Solid Preparation Drug Market Share by Players (2018-2023)

    Table 17. Global Top Solid Preparation Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Preparation Drug as of 2022)

    Table 18. Ranking of Global Top Solid Preparation Drug Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Solid Preparation Drug Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Solid Preparation Drug Product Solution and Service

    Table 22. Date of Enter into Solid Preparation Drug Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Solid Preparation Drug Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Solid Preparation Drug Revenue Market Share by Type (2018-2023)

    Table 26. Global Solid Preparation Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Solid Preparation Drug Revenue Market Share by Type (2024-2029)

    Table 28. Global Solid Preparation Drug Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Solid Preparation Drug Revenue Market Share by Application (2018-2023)

    Table 30. Global Solid Preparation Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Solid Preparation Drug Revenue Market Share by Application (2024-2029)

    Table 32. North America Solid Preparation Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Solid Preparation Drug Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Solid Preparation Drug Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Solid Preparation Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Solid Preparation Drug Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Solid Preparation Drug Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Solid Preparation Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Solid Preparation Drug Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Solid Preparation Drug Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Solid Preparation Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Solid Preparation Drug Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Solid Preparation Drug Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Solid Preparation Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Solid Preparation Drug Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Solid Preparation Drug Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Johnson & Johnson Company Detail

    Table 48. Johnson & Johnson Business Overview

    Table 49. Johnson & Johnson Solid Preparation Drug Product

    Table 50. Johnson & Johnson Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 51. Johnson & Johnson Recent Development

    Table 52. Novartis Company Detail

    Table 53. Novartis Business Overview

    Table 54. Novartis Solid Preparation Drug Product

    Table 55. Novartis Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 56. Novartis Recent Development

    Table 57. Roche Company Detail

    Table 58. Roche Business Overview

    Table 59. Roche Solid Preparation Drug Product

    Table 60. Roche Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 61. Roche Recent Development

    Table 62. AbbVie Company Detail

    Table 63. AbbVie Business Overview

    Table 64. AbbVie Solid Preparation Drug Product

    Table 65. AbbVie Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 66. AbbVie Recent Development

    Table 67. Merck & Co. Company Detail

    Table 68. Merck & Co. Business Overview

    Table 69. Merck & Co. Solid Preparation Drug Product

    Table 70. Merck & Co. Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 71. Merck & Co. Recent Development

    Table 72. Bristol Myers Squibb Company Detail

    Table 73. Bristol Myers Squibb Business Overview

    Table 74. Bristol Myers Squibb Solid Preparation Drug Product

    Table 75. Bristol Myers Squibb Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 76. Bristol Myers Squibb Recent Development

    Table 77. GlaxoSmithKline Company Detail

    Table 78. GlaxoSmithKline Business Overview

    Table 79. GlaxoSmithKline Solid Preparation Drug Product

    Table 80. GlaxoSmithKline Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 81. GlaxoSmithKline Recent Development

    Table 82. Pfizer Company Detail

    Table 83. Pfizer Business Overview

    Table 84. Pfizer Solid Preparation Drug Product

    Table 85. Pfizer Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 86. Pfizer Recent Development

    Table 87. Sanofi Company Detail

    Table 88. Sanofi Business Overview

    Table 89. Sanofi Solid Preparation Drug Product

    Table 90. Sanofi Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 91. Sanofi Recent Development

    Table 92. Takeda Company Detail

    Table 93. Takeda Business Overview

    Table 94. Takeda Solid Preparation Drug Product

    Table 95. Takeda Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 96. Takeda Recent Development

    Table 97. AstraZeneca Company Detail

    Table 98. AstraZeneca Business Overview

    Table 99. AstraZeneca Solid Preparation Drug Product

    Table 100. AstraZeneca Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 101. AstraZeneca Recent Development

    Table 102. Bayer Company Detail

    Table 103. Bayer Business Overview

    Table 104. Bayer Solid Preparation Drug Product

    Table 105. Bayer Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 106. Bayer Recent Development

    Table 107. Eli Lilly & Co. Company Detail

    Table 108. Eli Lilly & Co. Business Overview

    Table 109. Eli Lilly & Co. Solid Preparation Drug Product

    Table 110. Eli Lilly & Co. Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 111. Eli Lilly & Co. Recent Development

    Table 112. Gilead Sciences Company Detail

    Table 113. Gilead Sciences Business Overview

    Table 114. Gilead Sciences Solid Preparation Drug Product

    Table 115. Gilead Sciences Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 116. Gilead Sciences Recent Development

    Table 117. Amgen Company Detail

    Table 118. Amgen Business Overview

    Table 119. Amgen Solid Preparation Drug Product

    Table 120. Amgen Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 121. Amgen Recent Development

    Table 122. Teva Company Detail

    Table 123. Teva Business Overview

    Table 124. Teva Solid Preparation Drug Product

    Table 125. Teva Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 126. Teva Recent Development

    Table 127. Boehringer Ingelheim Company Detail

    Table 128. Boehringer Ingelheim Business Overview

    Table 129. Boehringer Ingelheim Solid Preparation Drug Product

    Table 130. Boehringer Ingelheim Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 131. Boehringer Ingelheim Recent Development

    Table 132. Biogen Company Detail

    Table 133. Biogen Business Overview

    Table 134. Biogen Solid Preparation Drug Product

    Table 135. Biogen Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 136. Biogen Recent Development

    Table 137. Astellas Company Detail

    Table 138. Astellas Business Overview

    Table 139. Astellas Solid Preparation Drug Product

    Table 140. Astellas Revenue in Solid Preparation Drug Business (2018-2023) & (US$ Million)

    Table 141. Astellas Recent Development

    Table 142. Research Programs/Design for This Report

    Table 143. Key Data Information from Secondary Sources

    Table 144. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Solid Preparation Drug Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Solid Preparation Drug Market Share by Type: 2022 VS 2029

    Figure 3. Tablet Features

    Figure 4. Capsules Features

    Figure 5. Other Features

    Figure 6. Global Solid Preparation Drug Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Solid Preparation Drug Market Share by Application: 2022 VS 2029

    Figure 8. Hospital Case Studies

    Figure 9. Retail Pharmacy Case Studies

    Figure 10. Other Case Studies

    Figure 11. Solid Preparation Drug Report Years Considered

    Figure 12. Global Solid Preparation Drug Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Solid Preparation Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Solid Preparation Drug Market Share by Region: 2022 VS 2029

    Figure 15. Global Solid Preparation Drug Market Share by Players in 2022

    Figure 16. Global Top Solid Preparation Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Preparation Drug as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Solid Preparation Drug Revenue in 2022

    Figure 18. North America Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Solid Preparation Drug Market Share by Country (2018-2029)

    Figure 20. United States Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Solid Preparation Drug Market Share by Country (2018-2029)

    Figure 24. Germany Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Solid Preparation Drug Market Share by Region (2018-2029)

    Figure 32. China Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Solid Preparation Drug Market Share by Country (2018-2029)

    Figure 40. Mexico Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Solid Preparation Drug Market Share by Country (2018-2029)

    Figure 44. Turkey Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Solid Preparation Drug Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Johnson & Johnson Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 47. Novartis Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 48. Roche Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 49. AbbVie Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 50. Merck & Co. Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 51. Bristol Myers Squibb Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 52. GlaxoSmithKline Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 53. Pfizer Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 54. Sanofi Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 55. Takeda Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 56. AstraZeneca Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 57. Bayer Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 58. Eli Lilly & Co. Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 59. Gilead Sciences Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 60. Amgen Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 61. Teva Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 62. Boehringer Ingelheim Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 63. Biogen Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 64. Astellas Revenue Growth Rate in Solid Preparation Drug Business (2018-2023)

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed